ZA869448B - Dihydropyridine spray,process for its preparation and its pharmaceutical use - Google Patents

Dihydropyridine spray,process for its preparation and its pharmaceutical use

Info

Publication number
ZA869448B
ZA869448B ZA869448A ZA869448A ZA869448B ZA 869448 B ZA869448 B ZA 869448B ZA 869448 A ZA869448 A ZA 869448A ZA 869448 A ZA869448 A ZA 869448A ZA 869448 B ZA869448 B ZA 869448B
Authority
ZA
South Africa
Prior art keywords
dihydropyridine
spray
preparation
pharmaceutical use
pharmaceutical
Prior art date
Application number
ZA869448A
Other languages
English (en)
Inventor
Ahmed Hegasy
Klaus-Dieter Raemsch
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of ZA869448B publication Critical patent/ZA869448B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
ZA869448A 1985-12-18 1986-12-17 Dihydropyridine spray,process for its preparation and its pharmaceutical use ZA869448B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19853544692 DE3544692A1 (de) 1985-12-18 1985-12-18 Dihydropyridinspray, verfahren zu seiner herstellung und seine pharmazeutische verwendung

Publications (1)

Publication Number Publication Date
ZA869448B true ZA869448B (en) 1987-09-30

Family

ID=6288696

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA869448A ZA869448B (en) 1985-12-18 1986-12-17 Dihydropyridine spray,process for its preparation and its pharmaceutical use

Country Status (12)

Country Link
US (1) US4857312A (it)
JP (1) JPS62155216A (it)
BE (1) BE905954A (it)
CA (1) CA1281654C (it)
CH (1) CH667203A5 (it)
DE (1) DE3544692A1 (it)
ES (1) ES2002668A6 (it)
FR (1) FR2592378B1 (it)
GB (1) GB2184654B (it)
GR (1) GR862915B (it)
IT (1) IT1199680B (it)
ZA (1) ZA869448B (it)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0579260A1 (en) * 1987-07-07 1994-01-19 Beecham Group Plc Use of a vasodilator for the treatment of pulmonary hypertension and/or right heart failure-related conditions
US5209933A (en) * 1990-01-10 1993-05-11 Syntex (U.S.A.) Inc. Long acting calcium channel blocker composition
US5141961A (en) * 1991-06-27 1992-08-25 Richrdson-Vicks Inc. Process for solubilizing difficulty soluble pharmaceutical actives
CN1054602C (zh) * 1993-04-19 2000-07-19 河北医学院 间－尼索地平及其合成方法
US5431916A (en) * 1993-04-29 1995-07-11 The Procter & Gamble Company Pharmaceutical compositions and process of manufacture thereof
US5484606A (en) * 1994-01-24 1996-01-16 The Procter & Gamble Company Process for reducing the precipitation of difficulty soluble pharmaceutical actives
US5478848A (en) * 1994-01-26 1995-12-26 Bayer Corporation Inhibition of arthritis by L-type calcium channel antagonists nimodipine, nisoldipine and nifedipine
HU214582B (hu) * 1994-07-26 1998-04-28 EGIS Gyógyszergyár Rt. Porlasztható, vérnyomáscsökkentő hatású gyógyszerkészítmény és eljárás előállítására
WO1996030738A1 (en) * 1995-03-28 1996-10-03 Innovex Biosciences Compositions and methods for permanently mounting biological specimens
DK0835098T3 (da) * 1995-06-27 2002-10-07 Boehringer Ingelheim Pharma Stabilt lægemiddelpræparat til frembringlese af drivgasfrie aerosoler
AU2190697A (en) * 1996-04-12 1997-11-07 Flemington Pharmaceutical Corporation Buccal polar spray or capsule
CN1233169A (zh) * 1996-10-14 1999-10-27 弗·哈夫曼-拉罗切有限公司 一种粉末状制剂的制备工艺
US20050287075A1 (en) * 1997-10-01 2005-12-29 Dugger Harry A Iii Buccal, polar and non-polar spray or capsule containing drugs for treating pain
US20040136915A1 (en) * 1997-10-01 2004-07-15 Dugger Harry A. Buccal, polar and non-polar spray containing atropine
US20030077227A1 (en) * 1997-10-01 2003-04-24 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system
US20030095927A1 (en) * 1997-10-01 2003-05-22 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating muscular and skeletal disorders
US20030077229A1 (en) * 1997-10-01 2003-04-24 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing cardiovascular or renal drugs
US20040136914A1 (en) 1997-10-01 2004-07-15 Dugger Harry A. Buccal, polar and non-polar spray containing ondansetron
US20040141923A1 (en) * 1997-10-01 2004-07-22 Dugger Harry A. Buccal, polar and non-polar spray containing alprazolam
US20050002867A1 (en) * 1997-10-01 2005-01-06 Novadel Pharma Inc. Buccal, polar and non-polar sprays containing propofol
US20090162300A1 (en) * 1997-10-01 2009-06-25 Dugger Iii Harry A Buccal, polar and non-polar spray containing alprazolam
US20030095926A1 (en) * 1997-10-01 2003-05-22 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the gastrointestinal tract or urinary tract
US20050281752A1 (en) * 1997-10-01 2005-12-22 Dugger Harry A Iii Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system
US20050163719A1 (en) * 1997-10-01 2005-07-28 Dugger Harry A.Iii Buccal, polar and non-polar spray containing diazepam
EP2042161A1 (en) * 1997-10-01 2009-04-01 Novadel Pharma Inc. Propellant-free spray composition comprising anti-emetic agent
US7632517B2 (en) * 1997-10-01 2009-12-15 Novadel Pharma Inc. Buccal, polar and non-polar spray containing zolpidem
US20030095925A1 (en) * 1997-10-01 2003-05-22 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating metabolic disorders
US20030082107A1 (en) * 1997-10-01 2003-05-01 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating an infectious disease or cancer
US20050180923A1 (en) * 1997-10-01 2005-08-18 Dugger Harry A.Iii Buccal, polar and non-polar spray containing testosterone
US20030190286A1 (en) * 1997-10-01 2003-10-09 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating allergies or asthma
US20030077228A1 (en) * 1997-10-01 2003-04-24 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating endocrine disorders
US20040136913A1 (en) * 1997-10-01 2004-07-15 Dugger Harry A. Buccal, polar and non-polar spray containing sumatriptan
US20030185761A1 (en) * 1997-10-01 2003-10-02 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating pain
KR100315872B1 (ko) * 1999-03-08 2001-12-22 류덕희 디히드로피리딘 유도체를 포함하는 지속성 제제의 제조방법
DE10142417A1 (de) * 2001-08-31 2003-03-20 Molecular And Clinical Drug Re Arzneimittel
DE10142416A1 (de) * 2001-08-31 2003-03-20 Molecular And Clinical Drug Re Verfahren zur Herstellung von Lösungen
GB0215749D0 (en) * 2002-07-09 2002-08-14 3M Innovative Properties Co Medicinal suspension aerosol model systems
JP5577021B2 (ja) 2005-02-17 2014-08-20 アボット・ラボラトリーズ 動物における障害を治療および予防するための薬剤組成物の経粘膜投与
JP2009534387A (ja) * 2006-04-19 2009-09-24 ノヴァデル ファーマ インコーポレイテッド 安定な含水アルコール性経口噴霧調剤物および方法
US20080171089A1 (en) * 2006-12-22 2008-07-17 Blondino Frank E Stable anti-nausea oral spray formulations and methods
EP2152247A4 (en) * 2007-05-10 2012-12-26 Novadel Pharma Inc COMPOSITIONS AND METHODS ANTI-INSOMNIA
US7985325B2 (en) * 2007-10-30 2011-07-26 Novellus Systems, Inc. Closed contact electroplating cup assembly
US20120289553A1 (en) * 2009-12-28 2012-11-15 Laboratorio Reig Jofre, S.A. Oral liquid pharmaceutical composition of nifedipine

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU432703A3 (it) * 1971-08-24 1974-06-15 Фридрих Боссерт, Вульф Фатер, Курт Бауер
US3920823A (en) * 1972-03-06 1975-11-18 Bayer Ag Use of unsymmetrical esters of n-substituted 1,4-dihydropyridine 3,5-dicarboxylic acid as cardio-vascular agents
DE2650013C3 (de) * 1976-10-30 1981-04-02 Bayer Ag, 5090 Leverkusen 1.4-Dihydro-2.6-dimethyl-4-(3-nitrophenyl)-3.5-pyridindicarbonsäureisopropyl-(2-propoxy-äthyl)-ester, Verfahren zu seiner Herstellung sowie ihn enthaltende Arzneimittel
GB1579818A (en) * 1977-06-07 1980-11-26 Yamanouchi Pharma Co Ltd Nifedipine-containing solid preparation composition
EP0001247A1 (en) * 1977-09-14 1979-04-04 Kanebo, Ltd. Pharmaceutical preparation containing nifedipine and a method for producing the same.
DE2815578C2 (de) * 1978-04-11 1986-01-16 Bayer Ag, 5090 Leverkusen Neue pharmazeutische Verwendung von Nimodipin
DE3021958A1 (de) * 1980-06-12 1981-12-24 Bayer Ag, 5090 Leverkusen 1,4-dihydropyridine, verfahren zu deren herstellung sowie diese enthaltende arzneimittel
JPS57167911A (en) * 1981-04-09 1982-10-16 Kyoto Yakuhin Kogyo Kk Liquid pharmaceutical of nifedipine
JPS58105913A (ja) * 1981-12-18 1983-06-24 Nippon Chemiphar Co Ltd ニフエジピン軟カプセル剤
DE3212736A1 (de) * 1982-04-06 1983-10-13 Bayer Ag, 5090 Leverkusen Verwendung von dihydropyridinen in arzneimitteln mit salidiuretischer wirkung
DE3307422A1 (de) * 1983-03-03 1984-09-06 Bayer Ag, 5090 Leverkusen Fluessigzubereitungen von dihydropyridinen, ein verfahren zu ihrer herstellung, sowie ihre verwendung bei der bekaempfung von erkrankungen
US4607041A (en) * 1983-04-27 1986-08-19 Fisons Plc Antihypertensive 2-phenyl Hantzsch dihydropyridines
DE3316510A1 (de) * 1983-05-06 1984-11-08 Bayer Ag Parenterale formulierung von nimodipin, ein verfahren zu ihrer herstellung sowie ihre verwendung bei der bekaempfung von erkrankungen
DE3326089A1 (de) * 1983-07-20 1985-02-07 Gödecke AG, 1000 Berlin Zur inhalation bestimmte darreichungsform von calcium-antagonisten
DE3376198D1 (en) * 1983-11-30 1988-05-11 Siegfried Ag Therapeutic coronary composition in the form of soft gelatine capsules
DE3414801A1 (de) * 1984-04-19 1985-10-24 Bayer Ag, 5090 Leverkusen 4-(nitrophenyl)-tetrahydropyridine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
EP0175671A1 (de) * 1984-08-23 1986-03-26 Kuhlemann & Co. Pharmazeutische Zubereitung sowie Verfahren zum Darreichen dieser pharmazeutischen Zubereitung

Also Published As

Publication number Publication date
GB2184654B (en) 1990-01-24
IT8622482A0 (it) 1986-11-27
FR2592378B1 (fr) 1991-07-05
GR862915B (en) 1987-04-16
CH667203A5 (de) 1988-09-30
DE3544692A1 (de) 1987-06-19
IT1199680B (it) 1988-12-30
CA1281654C (en) 1991-03-19
FR2592378A1 (fr) 1987-07-03
GB2184654A (en) 1987-07-01
ES2002668A6 (es) 1988-09-16
US4857312A (en) 1989-08-15
DE3544692C2 (it) 1992-06-17
BE905954A (fr) 1987-06-17
JPS62155216A (ja) 1987-07-10
GB8629874D0 (en) 1987-01-28

Similar Documents

Publication Publication Date Title
GB2184654B (en) Dihydropyridine spray, process for its preparation and its pharmaceutical use
LTIP1467A (en) Tertiary hydroxyalkylxantines, process for the preparation thereof and pharmaceutical composition containing them
IL78569A (en) Substituted carboxamido-benz-heterocyclyl-methyl-benzoic acids,process for their preparation and pharmaceutical compositions comprising them
EP0187620A3 (en) Pyrrolo-pyrroles, process for their preparation and use
EP0201741A3 (en) Dipeptide derivatives, processes for preparing them, pharmaceutical composition and use
PT83143A (en) Process for preparing 2-thiomethyl-substituted-1,4-dihydropyridines and pharmaceutical compositions containing them
GR860849B (en) 4-demethyl -4- epipodophyllotoxin derivatives process for their preparation and their use as medicaments
AR243499A1 (es) Un procedimiento para la preparacion de derivados de sulfonanilida.
DE3664774D1 (en) Novel 1,8-naphthyridine derivatives and processes for preparation thereof
ZA866529B (en) Azolyl-cyclopropyl-ethanol derivatives,processes for their preparation and their use
IL78576A0 (en) 5-pyrimidinecarboxamide,processes for the preparation thereof and pharmaceutical compositions containing same
ZA865328B (en) Oxa-thia and d1-azabicycloalkane derivatives;process for their preparation and their use as pharmaceuticals
GR862249B (en) Dihydropyridin-2-hydroxyamine process for their preparation and their use as medicaments
EP0216127A3 (en) 6-phenoxymethyl-4-hydroxytetrahydropyran-2-ones, process for their preparation, their use as medicines, pharmaceutical compositions and intermediates
AR242193A1 (es) Procedimiento para la preparacion de 4-/4,5-dihidro-2-imidazolil(o 2-oxazolil o 2-tiazolil)7-amino-5(o 3,5)-halogeno benzamida e intermediarios de sintesis utilizados segun dicho procedimiento.
DE3664635D1 (en) 7-hydroxyguanine compounds, process for preparing said compounds, pharmaceutical composition, and use thereof
GB2179347B (en) Methylenedioxyphenanthrene and -stilbene derivatives, processes for the preparation thereof and pharmaceutical compositions containing them
EP0225866A3 (en) Quinazoline derivatives, process for their preparation, pharmaceutical compositions containing them and their use
GR3001052T3 (en) Novel 16,17-acetalsubstituted pregnane-21-oic acid derivatives, process for the preparation thereof and pharmaceutical preparation containing them
PT83231A (en) Process for the preparation of gem-dihalo-1,8-diamino-4-aza-octanes and of pharmaceutical compositions containing the same
ZA861074B (en) Novel 1,8-naphthyridine derivatives and processes for preparation thereof
ZA864487B (en) Anti-thorombosis agent based on glycosaminagolycan,process for its preparation,and pharmaceutical compositions
DE3661830D1 (en) 2,4-dichlorothiazole derivatives and process for their preparation
EP0211303A3 (en) 2-acyl-5-methyl furans, process for their preparation and their use
AR241906A1 (es) Un procedimiento para la preparacion de derivados de n-(2-imidazolinil-alquil)-4-amino-benzamida y sus sales farmacologicamente aceptables